O-linked glycoforms of polypeptides and method to manufacture them

Details for Australian Patent Application No. 2005243427 (hide)

Owner Novo Nordisk Health Care AG

Inventors Klausen, Niels Kristian

Agent Shelston IP

Pub. Number AU-B-2005243427

PCT Pub. Number WO2005/111225

Priority PA 2004 00712 04.05.04 DK; PA 2004 00882 04.06.04 DK

Filing date 3 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 22 July 2010

International Classifications

C12P 21/00 (2006.01) Preparation of peptides or proteins

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111225 Priority application(s): WO2005/111225

22 July 2010 Application Accepted

  Published as AU-B-2005243427

4 November 2010 Opposition Lodged

  Almond-Martin, C. has lodged an opposition against Novo Nordisk Health Care AG.

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243432-Surface-modified inorganic fillers and pigments

2005243418-Cyclopeptide derivatives with antiintegrin activity